News About: Pharm. Industry
Viread takes on Baraclude
Yuhan Corp. is enjoying brisk sales of its new anti-hepatitis B drug, Viread (tenofovir) developed by Gilead Sciences as a nucleotide reverse transcriptase inhibitor.
According to IMS data, sales of Viread reached ...
Government Oks sales of locally-produced Japanese encephalitis vaccine
Korea’s health authorities gave the green light to a local pharmaceutical company on Aug. 9 to sell the nation’s first vaccine for Japanese encephalitis.
Boyung Pharm developed an inactivated Vero cell-derived vacc...
Covert kickbacks for doctors
The government is stepping up its crackdown on the long-standing practice of offering and receiving kickbacks in the medical community. Yet it remains to be seen whether the illegal practice will be uprooted this time...
CrystalGenomics buys Hwail for 46.8 billion won
Korea’s emerging biotech company CrystalGenomics Inc. said Tuesday it reached a deal to buy Hwail Pharm, a pharmaceutical raw material manufacturer, for 46.8 billion won.
The stock purchase agreement calls for the ...
Green Cross wins $12.5 million flu vaccine contract
Green Cross Corp. has won a contract to supply $12.5 million worth of seasonal influenza vaccines to the Pan American Health Organization (PAHO), the Korean pharmaceutical firm said Tuesday.
A company spokesman sai...
Ilyang recognized as foreign quasi-drug manufacturer in Japan
Ilyang Pharm said Tuesday its Yongin plant has been recognized as an eligible foreign manufacturing facility of quasi-drugs from the Japanese Health, Labor and Welfare.
Under the Japanese health ministry’s recognit...
16 drugmakers rebound in first half
The nation’s sixteen leading drug manufacturers may have bottomed out in earnings in the first half of this year as their sales and operating profits have shown signs of improvement on the back of robust sales of flag...
Whanin forms partnership with Abbott Korea
Whanin Pharm announced on last Thursday that it has entered into a partnership agreement with Abbott Korea for the marketing and distribution of the latter’s Depakote (divalproex sodium) from next month in Korea.
W...
New combination approved by MFDS for s-amlodipine/valsartan
Ahngook Pharm said on Tuesday that the Ministry of Food and Drug Safety (MFDS) had given the green light to Levosartan, which combines the two most commonly prescribed hypertension medicines in one tablet (5mg/160mg, ...
Duplicate price scheme proposed for exportable medicines
The local research organization has recommended a “duplicate price” scheme in which the manufacturer of exportable drugs would refund to the National Health Insurance Corporation the price difference existing between ...
